Pfizer's revenue is down again due to patent loss. Delivering these blockbuster drugs transdermally is a win for us, Pfizer, and more importantly, the patient.
- Forums
- ASX - By Stock
- Pfizer
Pfizer's revenue is down again due to patent loss. Delivering...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable